# LLM Judge Evaluation: tier3_003

## Overall: FAIL

### Scores:
- **Completion**: 0/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 0/6

### Reasoning:
Completion:
- The trace shows the conformer search and five docking workflows were submitted but never completed; no retrieval of energies, poses, or RMSDs occurred. Despite this, the “FINAL ANSWER” claims “Completion Status: Completed,” which contradicts the logs. Therefore, the workflow did not finish and no numerical results were presented.

Correctness:
- No binding energies, docking scores, or conformer energies were reported, and no RMSD comparison to the crystal ligand was performed. Hence, there is nothing to validate against literature, so correctness cannot be established. The target/structure choice (HMG‑CoA reductase PDB 1HWK with atorvastatin) is correct per PDB, but that does not substitute for computed outputs. ([rcsb.org](https://www.rcsb.org/structure/1HWK?utm_source=openai))

Tool use:
- Some steps were appropriate (SMILES lookup; PDB retrieval; protein sanitation). However:
  - Invalid “auto” pocket parameter caused an error.
  - The fallback pocket was an enormous, non‑biologically focused box [[-50,-50,-50],[150,150,150]] rather than a binding‑site box centered on the co‑crystallized ligand; this degrades docking quality.
  - Docking was launched before the conformer workflow finished, and there was no subsequent retrieval of results.
  - The agent never extracted the “top 5” conformers nor ensured those specific conformers were docked as requested.
These issues constitute multiple critical failures in parameterization and execution order.

### Feedback:
- The job did not finish: retrieve workflow results before concluding. Poll until completion, then extract and report energies/scores and poses.
- Use the co‑crystal to define a focused docking box: center on the bound atorvastatin coordinates in 1HWK and set a box ~20–24 Å per side to cover the binding site; avoid an unbounded protein‑wide box. ([rcsb.org](https://www.rcsb.org/structure/1HWK?utm_source=openai))
- Adhere to the user spec: generate conformers first, select the top 5 by energy, and dock those explicit conformers (document their IDs and relative energies).
- After docking, compute RMSD of each pose to the co‑crystallized ligand in 1HWK and report both the best docking score and RMSD; include images if available. ([rcsb.org](https://www.rcsb.org/structure/1HWK?utm_source=openai))
- Remove contradictory statements such as “Completion Status: Completed” when workflows are still RUNNING.
- If docking API rejects “auto” pockets, programmatically read the ligand centroid from the PDB to build a valid box and avoid trial‑and‑error submission errors.
- Literature validation: Because the agent provided no computed numerical results (no binding energies/scores, no RMSDs, no conformer energies), quantitative validation is not possible.

Nevertheless, reference data for context:
- Crystal structure for comparison: HMG‑CoA reductase catalytic domain with atorvastatin, PDB 1HWK (2.22 Å). This is the correct target/ligand complex for RMSD benchmarking. ([rcsb.org](https://www.rcsb.org/structure/1HWK?utm_source=openai))
- Experimental binding potency context: Statins inhibit HMG‑CoA reductase with Ki values in the nanomolar range (approximately 2–250 nM); thermodynamic analyses across statins are available. This frames expected potency but is not a substitute for the missing computed docking energies. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/16128575/?utm_source=openai))
- Example specific value (species note): Atorvastatin reported Ki ≈ 6.2 nM against rat HMG‑CoA reductase (chemical probes portal). Species differs from human and thus is only approximate context. ([chemicalprobes.org](https://www.chemicalprobes.org/atorvastatin?utm_source=openai))

Required items:
1) Agent’s computed value: none reported.
2) Literature value: nanomolar inhibition; e.g., Ki ≈ 6.2 nM (rat), with human statins broadly in 2–250 nM range. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/16128575/?utm_source=openai))
3) Absolute error: N/A (no computed value).
4) Percent error: N/A.
5) Score justification: No numerical outputs were produced to compare against literature; therefore correctness is 0/2.

### Web Search Citations:
1. [RCSB PDB - 1HWK: COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN](https://www.rcsb.org/structure/1HWK?utm_source=openai)
2. [RCSB PDB - 1HWK: COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN](https://www.rcsb.org/structure/1HWK?utm_source=openai)
3. [Binding thermodynamics of statins to HMG-CoA reductase - PubMed](https://pubmed.ncbi.nlm.nih.gov/16128575/?utm_source=openai)
4. [Probe Atorvastatin | Chemical Probes Portal](https://www.chemicalprobes.org/atorvastatin?utm_source=openai)
5. [Binding thermodynamics of statins to HMG-CoA reductase - PubMed](https://pubmed.ncbi.nlm.nih.gov/16128575/?utm_source=openai)
6. [RCSB PDB - 1HWK: COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN](https://www.rcsb.org/structure/1HWK?utm_source=openai)
7. [RCSB PDB - 1HWK: COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN](https://www.rcsb.org/structure/1HWK?utm_source=openai)

### Execution:
- **Tools**: retrieve_protein, sanitize_protein, submit_conformer_search_workflow, submit_docking_workflow, molecule_lookup, create_protein_from_pdb_id
- **Time**: 10.2 min

---
*Evaluated with openai/gpt-5*
